Xcout Intel
Character Biosciences
Character Biosciences is a biotechnology company that uses human genetics and functional genomics to discover and develop precision medicines. Its work has focused particularly on genetically informed therapies for age-related diseases, including ophthalmic conditions such as age-related macular degeneration.
Subscribe to see Character Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Character Biosciences at a glance
Character Biosciences is a biotech company headquartered in United States. Its most recent funding round raised $8.9M in September 2025. Xcout tracks 18 named people at Character Biosciences, including Cheng Zhang (CEO, CFO, and Secretary). Xcout recorded 1 job posting from Character Biosciences in the last 90 days.
Character Biosciences leadership
- Cheng ZhangCEO, CFO, and Secretary
- Daniel Elgort, PhDChief Data and Analytics Officer
- Erik Karrer, PhDChief Scientific Officer
- Robert KimChief Medical Officer
- Cheng ZhangCEO, Co-Founder
- Will KrauseSVP, Finance
12 more named people on record for Character Biosciences, with roles, board committees and tenure — see the full roster →
Character Biosciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8.9M | — | |
| Series B | $17M | 1 named | |
| SEC Form D filing | $48.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Character Biosciences
Xcout recorded 1 job posting from Character Biosciences in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Character Biosciences's hiring signals →
Investors
Character Biosciences competitors
A few of Character Biosciences's closest competitors — see the full list of competitors and alternatives →
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Get Character Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Character Biosciences in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access